FMI
BBIO icon

F/M Investments’s BridgeBio Pharma BBIO Stock Holding History

F/M Investments’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Sell
18,741
-35,858
-66% -$2.51M 0.07% 150
2026
Q1 		$4.05M Buy
54,599
+3,427
+7% +$248K 0.27% 75
2025
Q4 		$3.91M Buy
51,172
+1,874
+4% +$123K 0.15% 169
2025
Q3 		$2.56M Sell
49,298
-31,766
-39% -$1.55M 0.1% 210
2025
Q2 		$3.5M Sell
81,064
-22,254
-22% -$809K 0.13% 176
2025
Q1 		$3.57M Buy
103,318
+6,120
+6% +$206K 0.14% 157
2024
Q4 		$2.67M Buy
+97,198
New +$2.51M 0.1% 194

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

F/M Investments's BBIO Position: Q2 2026 in Review

F/M Investments reduced its BridgeBio Pharma (BBIO) stake by 66% in Q2 2026, selling an estimated $2.51M and leaving 18,741 shares worth $1.4M. The position accounts for 0.07% of the portfolio, ranked #150.

F/M Investments first reported a position in BBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.05M in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • F/M Investments held 18,741 shares of BridgeBio Pharma worth $1.4M as of Q2 2026.
  • F/M Investments sold 35,858 BridgeBio Pharma shares in Q2 2026, an estimated $2.51M.
  • BridgeBio Pharma made up 0.07% of F/M Investments's portfolio in Q2 2026, its #150 holding.
  • F/M Investments first reported a position in BridgeBio Pharma in Q4 2024 and has held it in 7 quarters since.
  • F/M Investments's BridgeBio Pharma position peaked at $4.05M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.